Skip to content

D&A at other companies

Boston Beer logo
Boston BeerSAM
$21.58M-5.4%
Cronos Group logo
Cronos GroupCRON
$3.73M+31.2%
Canopy Growth Corporation logo
Canopy Growth CorporationCGC
$4.75M-20.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$597K-1.2%
Opko Health logo
Opko HealthOPK
$22.2M-5.5%
PBH
Prestige Consumer HealthcarePBH
$8.35M+15.2%

Other financials

Income statement

See full
Revenue$206.7M+11.3%
Gross profit$55.0M+5.7%
Operating income-$26.4M+96.5%
Net income-$26.6M+96.6%
EPS (diluted)-$0.24+97.2%

Balance sheet

See full
Cash & equivalents$204.6M+2.3%
Total debt$211.4M-6.9%
Total equity$1.6B-42.9%
Total assets$2.1B-39.0%

Cash flow

See full
Operating cash flow-$21.9M-281%
CapEx$6.3M-34.8%
Free cash flow-$19.1M

Valuation

See full
Market cap$538.85M+47.3%
Enterprise value$545.59M+46.8%
P/S0.6×+0.2×

Profitability

See full
Gross margin30.9%+2.9pp
Operating margin-103.5%-198pp
Net margin-156.1%+89.5pp
FCF margin-15.5%

Returns & leverage

See full
Return on equity-62.5%-1,636pp
Debt / equity0.1×+0.1×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Tilray Brands, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentForAmortization.

The official record: Tilray Brands, Inc.’s 10-Q, filed April 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tilray Brands, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tilray Brands, Inc.'s D&A?
Tilray Brands, Inc. (TLRY) reported D&A of $16.74M in Q4 2025.
How has Tilray Brands, Inc.'s D&A changed year-over-year?
Tilray Brands, Inc.'s D&A decreased by 50.1% year-over-year, from $33.55M to $16.74M.
What is the long-term trend for Tilray Brands, Inc.'s D&A?
Over 4 years (2021 to 2025), Tilray Brands, Inc.'s D&A has grown at a 27.6% compound annual growth rate (CAGR), from $50.29M to $133.49M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.